Brief: Bonesupport - Solario Study Meets Its Primary Endpoints

BoneSupport Holding AB

26/09/2024 10:06

Sept 26 (Reuters) - Bonesupport Holding AB  BONEX.ST :
    * SOLARIO STUDY MEETS ITS PRIMARY ENDPOINTS - BONE
SUBSTITUTE WITH
LOCAL ANTIBIOTICS ENABLES REDUCED SYSTEMIC ANTIBIOTIC TREATMENT
    * GROUP THAT RECEIVED SHORTER ANTIBIOTIC TREATMENT EXHIBITED
SIGNIFICANTLY REDUCED SIDE EFFECTS COMPARED TO STANDARD
TREATMENT

Source text for Eikon:  ID:nMFN9s632Z 
Further company coverage:  BONEX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))